Parse Bio Pools Further Funding
Seattle-based single cell analysis firm Parse Bio is announcing this morning a $41.5M Series B round of funding, pushing their total raise just over $50M. Parse uses chemical fixation to lock biomolecules onto their enclosing cells or nuclei, which can then be manipulated without releasing their contents. This enables a series of split-label-pool operations to tag the molecules of interest with barcodes so that in the end each cell has a unique barcode. The protocol requires no specialized instrument... Читать дальше...